Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Shima Safikhani"'
Autor:
April N. Naegeli, Jennifer Hanlon, Katharine S. Gries, Shima Safikhani, Anna Ryden, Mira Patel, Mabel Crescioni, Margaret Vernon
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 2, Iss 1, Pp 1-9 (2018)
Abstract Background Despite the importance of response option selection for patient-reported outcome measures, there seems to be little empirical evidence for the selected scale type. This article provides an overview of the published research on res
Externí odkaz:
https://doaj.org/article/60f28ec339154862a57c676da425a5e9
Autor:
Katharine Gries, Pamela Berry, Magdalena Harrington, Mabel Crescioni, Mira Patel, Katja Rudell, Shima Safikhani, Sheryl Pease, Margaret Vernon
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 2, Iss 1, Pp 1-14 (2018)
Abstract Background In the development of patient-reported outcome (PRO) instruments, little documentation is provided on the justification of response scale selection. The selection of response scales is often based on the developers’ preferences
Externí odkaz:
https://doaj.org/article/29de06cef59f4d348ff58b59257382a0
Autor:
Shima Safikhani, Katharine S. Gries, Jeremiah J. Trudeau, David Reasner, Katja Rüdell, Stephen Joel Coons, Elizabeth Nicole Bush, Jennifer Hanlon, Lucy Abraham, Margaret Vernon
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 2, Iss 1, Pp 1-9 (2018)
Abstract Background The purpose of this literature review was to examine the existing patient-reported outcome measurement literature to understand the empirical evidence supporting response scale selection in pain measurement for the adult populatio
Externí odkaz:
https://doaj.org/article/0c30f7749ae44a14a700b487c3ddec86
Autor:
N. Chen, Miriam Kimel, Arijit Ganguli, Shima Safikhani, Mary Cifaldi, Dennis A. Revicki, Sanjoy Roy
Publikováno v:
Value in Health. 18(8):1008-1015
ObjectiveThe objective was to evaluate the psychometric properties of the Rheumatoid Arthritis-Work Instability Scale (RA-WIS) in a clinical trial setting.MethodsSecondary analyses were conducted using data from a 56-week, randomized controlled trial
Autor:
Margaret Vernon, Lucy Abraham, David S. Reasner, Shima Safikhani, Katharine S. Gries, Elizabeth Nicole Bush, Katja Rüdell, Jennifer Hanlon, Stephen Joel Coons, Jeremiah J. Trudeau
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 2, Iss 1, Pp 1-9 (2018)
Background The purpose of this literature review was to examine the existing patient-reported outcome measurement literature to understand the empirical evidence supporting response scale selection in pain measurement for the adult population. Method
Autor:
Magdalena Harrington, Margaret Vernon, Mabel Crescioni, Katharine S. Gries, Sheryl Pease, Pamela Berry, Shima Safikhani, Katja Rüdell, Mira Patel
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 2, Iss 1, Pp 1-14 (2018)
Background In the development of patient-reported outcome (PRO) instruments, little documentation is provided on the justification of response scale selection. The selection of response scales is often based on the developers’ preferences or therap
Autor:
Thomas Babcock, Daniel Cassidy, Barry K. Herman, Shima Safikhani, David Hengerer, Norman Atkins, Andy Kim, Samuel Agus, William R Lenderking
Publikováno v:
Postgraduate Medicine. 126:52-63
Background Binge eating disorder (BED) is now a formal diagnosis in the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5). However, post-DSM-5 patient profiles and viewpoints on BED diagnosis and treatment remain unclear. T
Autor:
Pierfranco Conte, Henri Roché, Gabriel N. Hortobagyi, Shima Safikhani, Patricia K. Corey-Lisle, Jill A. Bell, Dennis A. Revicki, Pralay Mukhopadhyay, Ronald Peck, L. Orsini
Publikováno v:
Cancer. 118:461-468
BACKGROUND: Combination therapy with ixabepilone and capecitabine (cape) is approved for use in patients with locally advanced/metastatic breast cancer that is resistant to treatment with anthracyclines or taxanes. The current study evaluated the tra
Autor:
Srividya Kotapati, Céleste Lebbé, Christian H. Ottensmeier, Alfons J.M. van den Eertwegh, Samuel Wagner, Shima Safikhani, Axel Hoos, Dennis A. Revicki, Gerald P. Linette, Paul Lorigan, Marianne Messina
Publikováno v:
Health and Quality of Life Outcomes
Health and Quality of Life Outcomes, Vol 10, Iss 1, p 66 (2012)
Health and Quality of Life Outcomes, 10:66. BioMed Central
Revicki, D A, van den Eertwegh, A J M, Lorigan, P, Lebbe, C, Linette, G, Ottensmeier, C H, Safikhani, S, Messina, M, Hoos, A, Wagner, S & Kotapati, S 2012, ' Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment ', Health and Quality of Life Outcomes, vol. 10, 66 . https://doi.org/10.1186/1477-7525-10-66
Health and Quality of Life Outcomes, Vol 10, Iss 1, p 66 (2012)
Health and Quality of Life Outcomes, 10:66. BioMed Central
Revicki, D A, van den Eertwegh, A J M, Lorigan, P, Lebbe, C, Linette, G, Ottensmeier, C H, Safikhani, S, Messina, M, Hoos, A, Wagner, S & Kotapati, S 2012, ' Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment ', Health and Quality of Life Outcomes, vol. 10, 66 . https://doi.org/10.1186/1477-7525-10-66
Background In an international, randomized Phase III trial ipilimumab demonstrated a significant overall survival benefit in previously treated advanced melanoma patients. This report summarizes health-related quality of life (HRQL) outcomes for ipil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c69abc0ff02cfd434d87ee00189363c
https://eprints.soton.ac.uk/396352/
https://eprints.soton.ac.uk/396352/
Autor:
Patricia K, Corey-Lisle, Ronald, Peck, Pralay, Mukhopadhyay, Lucinda, Orsini, Shima, Safikhani, Jill A, Bell, Gabriel, Hortobagyi, Henri, Roche, Pierfranco, Conte, Dennis A, Revicki
Combination therapy with ixabepilone and capecitabine (cape) is approved for use in patients with locally advanced/metastatic breast cancer that is resistant to treatment with anthracyclines or taxanes. The current study evaluated the trade-off betwe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::efbc6c171705b7036dbca015ab92a571
https://hdl.handle.net/11380/738546
https://hdl.handle.net/11380/738546